Nanotechnology Community

What factors should be considered when formulating nanoparticles for targeted drug delivery? And what are the current challenges of achieving precise targeting using nanoparticles? 

Hi Achref,

Great question.

Factors should be considered when formulating nanoparticles for targeted drug delivery

The hydrophilic or lipophilic nature of drugs or biologics should be considered. For achieving high hydrophilic drug loading within nanoparticles, it is recommended to use hydrophilic polymers or lipids in the formulation of nanoparticles and vice versa. Another factor to consider is the desired size range and shape. The surface charge of nanoparticles influences cellular and tissue interactions as well as their stability in the bloodstream and tissues. There are several methods available for the preparation of nanoparticles, and by considering the advantages and limitations of these methods, a suitable one can be selected. The selection of the method is also influenced by the properties of the polymer and the drug. Along with particle size, the location and characteristics of the disease site where nanoparticles will be targeted are crucial factors. The stability and release profile will dictate the availability of the drug or biologic at the site of action. Surface modification with targeting moieties (e.g., proteins, aptamers, antibodies, peptides) can enhance specificity to target cells or tissues. PEGylation will provide salt and serum stability and extend the circulatory time of nanoparticles. The route of administration should also be considered, as the size range may vary based on the route to achieve maximum delivery of nanoparticles. For safety, the biocompatibility and biodegradability of nanoparticles should be considered.

The current challenges of achieving precise targeting using nanoparticles are:

1. Most nanoparticles have a broader particle size distribution, and thus achieving the desired size range and percentage drug load for exerting efficacy is one of the major challenges. Most nanoparticles have less than 5-10% drug loading. Therefore, achieving a higher percentage of drug load within nanoparticles is one of the challenging aspects.
2. The delivery of nanoparticles from the route of administration to the site of action.
3. The characteristics of the site of action and targeted tissues decide the percentage of the dose reaching to exert therapeutic effects.
4. The stability of nanoparticles in storage conditions is essential. For example, for liposomes, the preferred storage would be 2-8°C.
5. The expression of specific receptors or antigens on the cells and tissues should be considered to achieve the desired target specificity and higher dose delivery.
6. The non-specific uptake of nanoparticles by healthy tissues, exerting off-target effects.
7. Based on the target site of action, the mucosal and other barriers should be identified, and essential strategies to overcome these barriers should be considered.
8. The immune system clearance based on the absorption and distribution of nanoparticles is an important challenge to consider.
9. The scaling up of nanoparticles manufacturing while ensuring quality and consistency is also a significant challenge in precise targeting. 

What factors should be considered when formulating nanoparticles for targeted drug delivery? And what are the current challenges of achieving precise targeting using nanoparticles? 

Hi Achref,

Great question.

Factors should be considered when formulating nanoparticles for targeted drug delivery

The hydrophilic or lipophilic nature of drugs or biologics should be considered. For achieving high hydrophilic drug loading within nanoparticles, it is recommended to use hydrophilic polymers or lipids in the formulation of nanoparticles and vice versa. Another factor to consider is the desired size range and shape. The surface charge of nanoparticles influences cellular and tissue interactions as well as their stability in the bloodstream and tissues. There are several methods available for the preparation of nanoparticles, and by considering the advantages and limitations of these methods, a suitable one can be selected. The selection of the method is also influenced by the properties of the polymer and the drug. Along with particle size, the location and characteristics of the disease site where nanoparticles will be targeted are crucial factors. The stability and release profile will dictate the availability of the drug or biologic at the site of action. Surface modification with targeting moieties (e.g., proteins, aptamers, antibodies, peptides) can enhance specificity to target cells or tissues. PEGylation will provide salt and serum stability and extend the circulatory time of nanoparticles. The route of administration should also be considered, as the size range may vary based on the route to achieve maximum delivery of nanoparticles. For safety, the biocompatibility and biodegradability of nanoparticles should be considered.

The current challenges of achieving precise targeting using nanoparticles are:

1. Most nanoparticles have a broader particle size distribution, and thus achieving the desired size range and percentage drug load for exerting efficacy is one of the major challenges. Most nanoparticles have less than 5-10% drug loading. Therefore, achieving a higher percentage of drug load within nanoparticles is one of the challenging aspects.
2. The delivery of nanoparticles from the route of administration to the site of action.
3. The characteristics of the site of action and targeted tissues decide the percentage of the dose reaching to exert therapeutic effects.
4. The stability of nanoparticles in storage conditions is essential. For example, for liposomes, the preferred storage would be 2-8°C.
5. The expression of specific receptors or antigens on the cells and tissues should be considered to achieve the desired target specificity and higher dose delivery.
6. The non-specific uptake of nanoparticles by healthy tissues, exerting off-target effects.
7. Based on the target site of action, the mucosal and other barriers should be identified, and essential strategies to overcome these barriers should be considered.
8. The immune system clearance based on the absorption and distribution of nanoparticles is an important challenge to consider.
9. The scaling up of nanoparticles manufacturing while ensuring quality and consistency is also a significant challenge in precise targeting. 

What factors should be considered when formulating nanoparticles for targeted drug delivery? And what are the current challenges of achieving precise targeting using nanoparticles? 

What factors should be considered when formulating nanoparticles for targeted drug delivery? And what are the current challenges of achieving precise targeting using nanoparticles? 

Hi Achref Cherif, 

Below, I have outlined key points that address your question:

Factors to Consider When Formulating Nanoparticles for Targeted Drug Delivery

1. Material Selection:

   • Biocompatibility and Biodegradability: Materials like PLGA, chitosan, and lipids are preferred to minimize toxicity and ensure safe breakdown in the body.
   • Surface Modification: Incorporating polymers like PEG can enhance stability and circulation time (PEGylation), reducing immune clearance.

2. Particle Size and Morphology:

   • Size: Ideal size typically ranges between 10-200 nm to ensure optimal circulation time and tissue penetration.
   • Shape: Spherical particles are more commonly used, but rod-like or disk-shaped nanoparticles may provide enhanced interaction with certain biological systems.

3. Surface Functionalization:

   • Ligands: Target-specific molecules like antibodies, aptamers, or peptides can be attached to the nanoparticle surface for receptor-mediated targeting.
   • Charge: A slightly negative or neutral charge reduces nonspecific interactions and improves targeting.

4. Drug Loading and Release Profile:

   • Encapsulation Efficiency: Ensuring a high drug payload while maintaining nanoparticle integrity.
   • Controlled Release: Achieved through polymer degradation rates, pH-responsive materials, or other stimuli-responsive mechanisms.

5. Stability:

   • Storage Stability: Prevention of aggregation or degradation during storage.
   • In Vivo Stability: Protection against enzymatic degradation and immune clearance in the bloodstream.

6. Targeting Mechanism:

   • Passive Targeting: Exploits the Enhanced Permeability and Retention (EPR) effect in tumors or inflamed tissues.
   • Active Targeting: Uses ligands to bind to specific receptors on target cells.

7. Toxicity and Immunogenicity:

   • Minimizing off-target effects and ensuring the nanoparticle components do not elicit adverse immune responses.

8. Scalability and Manufacturing:

   • Formulation methods must be scalable for clinical production while maintaining reproducibility and cost-effectiveness.

-------------------------

Kazi Akramuddaula

MS in Pharmaceutical Nanotechnology

University of South Florida, USA

What factors should be considered when formulating nanoparticles for targeted drug delivery? And what are the current challenges of achieving precise targeting using nanoparticles? 

Thank you for your detailed response Kazi Akramuddaula!

You mentioned that the optimal size for nanoparticles should be between 10 and 200 nm. What technologies are best to achieve a uniform particle size in that range? 

Hi Achref Cherif, 

Below, I have outlined key points that address your question:

Factors to Consider When Formulating Nanoparticles for Targeted Drug Delivery

1. Material Selection:

   • Biocompatibility and Biodegradability: Materials like PLGA, chitosan, and lipids are preferred to minimize toxicity and ensure safe breakdown in the body.
   • Surface Modification: Incorporating polymers like PEG can enhance stability and circulation time (PEGylation), reducing immune clearance.

2. Particle Size and Morphology:

   • Size: Ideal size typically ranges between 10-200 nm to ensure optimal circulation time and tissue penetration.
   • Shape: Spherical particles are more commonly used, but rod-like or disk-shaped nanoparticles may provide enhanced interaction with certain biological systems.

3. Surface Functionalization:

   • Ligands: Target-specific molecules like antibodies, aptamers, or peptides can be attached to the nanoparticle surface for receptor-mediated targeting.
   • Charge: A slightly negative or neutral charge reduces nonspecific interactions and improves targeting.

4. Drug Loading and Release Profile:

   • Encapsulation Efficiency: Ensuring a high drug payload while maintaining nanoparticle integrity.
   • Controlled Release: Achieved through polymer degradation rates, pH-responsive materials, or other stimuli-responsive mechanisms.

5. Stability:

   • Storage Stability: Prevention of aggregation or degradation during storage.
   • In Vivo Stability: Protection against enzymatic degradation and immune clearance in the bloodstream.

6. Targeting Mechanism:

   • Passive Targeting: Exploits the Enhanced Permeability and Retention (EPR) effect in tumors or inflamed tissues.
   • Active Targeting: Uses ligands to bind to specific receptors on target cells.

7. Toxicity and Immunogenicity:

   • Minimizing off-target effects and ensuring the nanoparticle components do not elicit adverse immune responses.

8. Scalability and Manufacturing:

   • Formulation methods must be scalable for clinical production while maintaining reproducibility and cost-effectiveness.

-------------------------

Kazi Akramuddaula

MS in Pharmaceutical Nanotechnology

University of South Florida, USA

What factors should be considered when formulating nanoparticles for targeted drug delivery? And what are the current challenges of achieving precise targeting using nanoparticles? 

What factors should be considered when formulating nanoparticles for targeted drug delivery? And what are the current challenges of achieving precise targeting using nanoparticles? 

Thanks for posting, @Achref Cherif! I wanted to add that we will be hosting an AMA about this topic later this month! A panel of AAPS leaders will host an exclusive Ask Me Anything (AMA) session on the Characterization of Nanoparticles, on January 27, 11am ET, in the AAPS Community platform.
This is a unique opportunity to chat with experts in the field and get answers to your most pressing questions about nanoparticle characterization. 

You can join the discussion on January 27 here.

I am tagging community leader @Mitra Mosharraf as well!

What factors should be considered when formulating nanoparticles for targeted drug delivery? And what are the current challenges of achieving precise targeting using nanoparticles?